Search Results 371-380 of 14761 for anti-TNF drugs

1. Undecylenic Acid (Topical Route) Description and Brand Names - Mayo Clinic

   However, compound undecylenic acid generally has been replaced by newer and more effective medicines for the treatment of fungus infections.

2. Steroid use in pneumonia - Mayo Clinic

   Odeyemi explains: "The use of adjunct anti-inflammatory therapy to potentially improve outcomes has been the most explored strategy. Inflammation is a hallmark ...

3. A Study to Evaluate Posaconazole to Treat Genetically-defined Patients with Active Crohn's Disease - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search ... anti-TNF, anti IL12/23, or anti-integrin therapy ...

4. Polymyxin B And Trimethoprim (Ophthalmic Route) Description and Brand Names - Mayo Clinic

   Polymyxin B and trimethoprim belong to the class of medicines known as antibiotics. They work by killing the bacteria or preventing their growth. This medicine ...

5. Sulfamethoxazole And Trimethoprim (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

6. Statins for the Treatment of NASH - Mayo Clinic

   Immune modulatory agents including systemic steroids, methotrexate, anti-TNF-? therapies (infliximab, adalimumab, etanercept) or anti-integrin therapy

7. Antihemophilic Factor (Recombinant) Porcine Sequence (Intravenous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Obizur. Descriptions. Antihemophilic factor (AHF) ...

8. Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects with Crohn's Disease and Who Participated and Successfully Completed M14-115 - Mayo Clinic

   This study will evaluate the long term efficacy, safety, and tolerability of repeated administration of adalimumab in subjects with Crohn's disease.

9. A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Drugs & Supplements A-Z ... OR has not had biologic therapy (TNF antagonists or vedolizumab) ... anti-tumor necrosis factors (TNFs) for at least 8 weeks.

10. Fentanyl (Transdermal Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...